2 trials changed in the last 30 days: 0 stopped, 1 with a notable change, 1 with a minor change only.
Primary endpoint(s) modified
Also in this update: Recruitment opened
Anhui Provincial HospitalPhase 2 NCT07793695 Registry history of NCT07793695 on ClinicalTrials.gov (opens the registry)
Updated
Registry marked status Unknown (sponsor has not verified the record since Jul 2024); last known: Not Yet Recruiting
Anhui Provincial HospitalPhase 3 NCT06539091 Registry history of NCT06539091 on ClinicalTrials.gov (opens the registry)
Changed
| First posted | Trial | Phase | Status |
|---|---|---|---|
| 2026-09-25 | NCT07841873 Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment… | Phase 2 | Not Yet Recruiting |
| 2026-09-21 | NCT07830576 Multimodal Survival Prediction Model for Colorectal Liver Metastases Post-Operation | Recruiting |
| Early Phase 1 | 7 | |
| Phase 1 | 9 | |
| Phase 1/2 | 2 | |
| Phase 2 | 12 | |
| Phase 3 | 4 | |
| Phase 4 | 3 |
| NCT ID | Title | Condition | Status | Updated |
|---|---|---|---|---|
| Phase 4 | ||||
| NCT07150624 | The Treatment of Liver Injury After Liver Resection With Polyene Phosphatidylcholine | Hepatocellular Carcinoma (HCC) | Recruiting | 2026-05-11 |
| NCT07619027 | Low- vs Standard-Dose TMP-SMX for Prevention of Pneumocystis Pneumonia After Kidney… | Pneumocystis Jirovecii Pneumonia | Not Yet Recruiting | 2026-06-01 |
| NCT07481656 | Effects of Recombinant Human Growth Hormone in Elderly Patients With Moderate to Severe… | Acute Brain Injuries | Not Yet Recruiting | 2026-03-19 |
| Phase 3 | ||||
| NCT06294691 | Effect of Stem Cell Infusion Time on aGVHD in Patients With Nonmalignant Hematologic… | Acute Graft-versus-host Disease | Recruiting | 2026-08-24 |
| NCT07047456 | Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies… | Acute Graft Versus Host Disease | Recruiting | 2025-12-23 |
| NCT06294678 | Effect of Stem Cell Infusion Time on aGVHD in Patients With Hematological Malignancies | Acute Graft-versus-host Disease | Active, Not Recruiting | 2025-12-31 |
| NCT06542549 | Efficacy and Safety of AK104 (PD-1/CTLA-4 Bispecial Antibody) Combined With Chemotherapy… | Advanced Ovarian Cancer | Not Yet Recruiting | 2024-08-07 |
| Phase 2 | ||||
| NCT07793695 | Oral Zinc Supplementation Combined With Targeted Immunotherapy for Unresectable or… | Hepatocellular Carcinoma | Recruiting | 2026-09-21 |
| NCT06898983 | Efficacy and Safety Study of Romiplostim N01 for Cancer Treatment-induced… | Cancer Treatment-induced Thrombocytopenia (CTIT) | Recruiting | 2026-08-24 |
| NCT07188103 | Ivonescimab Plus Short-Course Hypofractionated Radiotherapy as Second-Line Therapy for… | Esophageal Squamous Cell Carcinoma | Recruiting | 2025-09-23 |
| NCT06664021 | Exploring the Efficacy and Safety of Tislelizumab in Combination With S-1 in the… | Intrahepatic Cholangiocarcinoma | Recruiting | 2025-01-10 |
| NCT06362967 | The Efficacy and Safety of Desensitation Regimen for Patients With High Titers of… | High Titers of Anti-HLA Antibody (MFI ≥5000) | Recruiting | 2024-12-18 |
| NCT06693791 | Romiplostim N01 for Platelet Recovery in Adult Hematologic Malignancies Patients… | Platelet Recovery After Umbilical Cord Blood Transplantation | Recruiting | 2024-11-18 |
| NCT06673498 | Lusutrombopag Combined With Recombinant Human Thrombopoietin for the Treatment of… | Thrombocytopenia | Recruiting | 2024-11-05 |
| NCT06498622 | Adjuvant Treatment of Patients With High Risk of Recurrent Hepatocellular Carcinoma With… | Hepatocellular Carcinoma | Recruiting | 2024-07-12 |
| NCT07841873 | Zanidatamab Combined With Liposomal Irinotecan and Capecitabine for Second-line Treatment… | Biliary Tract Cancer | Not Yet Recruiting | 2026-10-01 |
| NCT07811375 | Perioperative Adebrelimab for Locally Advanced Cervical Cancer | Locally Advanced Cervical Cancer | Not Yet Recruiting | 2026-09-10 |
| NCT07128251 | A Single-Arm, Multicenter, Exploratory Clinical Study of Transarterial Chemoembolization… | Hepatocellular Carcinoma (HCC) | Not Yet Recruiting | 2025-08-17 |
| NCT06480630 | Effectiveness and Safety of a Single-Center Clinical Study on a CD25 Monoclonal… | Acute Graft Versus Host Disease | Not Yet Recruiting | 2024-06-28 |
| Phase 1/2 | ||||
| NCT05937438 | Postoperative Radiotherapy Followed by Immunotherapy for Locally Advanced Esophageal… | Esophageal Carcinoma | Recruiting | 2025-01-29 |
| NCT06527898 | Hypofractionated Radiotherapy Combined with Immunotherapy for Limited-stage Small-cell… | Small-cell Lung Cancer | Recruiting | 2024-09-19 |
| Phase 1 | ||||
| NCT06232083 | A Multi Tumor, Open Phase I Clinical Study on the Progression of First-line Anti-tumor… | Lung Cancer | Recruiting | 2025-07-09 |
| NCT06558253 | The Safety and Efficacy of Coenzyme I for Injection in Promoting Hematopoietic Recovery… | Hematopoietic Recovery | Recruiting | 2024-12-18 |
| NCT07523464 | Centrally Confined 8Gy/1f to Tumor Core Followed by Concurrent Chemoradiotherapy for… | Locally-Advanced Non-Small Cell Lung Cancer | Not Yet Recruiting | 2026-04-13 |
| NCT07131085 | QH101 Cell Therapy Relapsed/Refractory(R/R) Acute Myeloid Leukemia(AML) and… | MDS | Not Yet Recruiting | 2025-08-20 |
Liver Cancer (9) · Esophageal Cancer (8) · Cervical Cancer (7) · Leukemia (5) · Lung Cancer (4) · Prostate Cancer (4) · Colorectal Cancer (3) · Ovarian Cancer (3) · Acute Lymphoblastic Leukemia (ALL) (2) · Cholangiocarcinoma (2)